Kestra Medical insider plans sale of 3,580 KMTS shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies, Ltd. (KMTS) has a proposed sale of 3,580 shares of common stock through Merrill Lynch on 08/04/2026, following the 07/17/2026 vesting of restricted stock unit awards granted as equity compensation. The Form 144 also lists prior sales over the last three months by reporting person Traci Umberger.
Key Figures
Key Terms
Form 144 regulatory
restricted stock unit financial
equity compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Kestra Medical Technologies (KMTS) report in this Form 144?
What recent KMTS stock sales are disclosed for Traci Umberger?
Is Kestra Medical Technologies (KMTS) itself selling stock in this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.